Literature DB >> 3756905

Oxidation of reduced cytosolic nicotinamide adenine dinucleotide by the malate-aspartate shuttle in the K-562 human leukemia cell line.

L López-Alarcón, M L Eboli.   

Abstract

The activity of the malate-aspartate shuttle for the reoxidation of reduced cytosolic nicotinamide adenine dinucleotide (NADH) by mitochondria was studied in a line of human myeloid leukemia cells (K-562). The tumor cells showed mitochondrial reoxidation of cytosolic NADH, as evidenced by the accumulation of pyruvate, when incubated aerobically with L-lactate. The involvement of the respiratory chain in the reoxidation of cytosolic NADH was demonstrated by the action of rotenone, antimycin A, and oligomycin which strongly inhibited the formation of pyruvate from added L-lactate. Moreover, pyruvate production was greatly inhibited by the transaminase inhibitor, aminooxyacetate. Under glycolytic conditions, in the presence of aminooxyacetate, the rate of pyruvate production was also markedly inhibited, the rate of lactate accumulation was stimulated, and at 60 min the cytosolic NADH/nicotinamide adenine dinucleotide (NAD) ratio had increased progressively about 5-fold with respect to untreated cells. The maximal rate of the malate-aspartate shuttle has also been established by addition of arsenite to inhibit mitochondrial oxidation of the pyruvate formed from added L-lactate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756905

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.

Authors:  Hui Yang; Lisha Zhou; Qian Shi; Yuzheng Zhao; Huaipeng Lin; Mengli Zhang; Shimin Zhao; Yi Yang; Zhi-Qiang Ling; Kun-Liang Guan; Yue Xiong; Dan Ye
Journal:  EMBO J       Date:  2015-03-09       Impact factor: 11.598

2.  Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype.

Authors:  Christopher D Wiley; Michael C Velarde; Pacome Lecot; Su Liu; Ethan A Sarnoski; Adam Freund; Kotaro Shirakawa; Hyung W Lim; Sonnet S Davis; Arvind Ramanathan; Akos A Gerencser; Eric Verdin; Judith Campisi
Journal:  Cell Metab       Date:  2015-12-10       Impact factor: 27.287

3.  Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase.

Authors:  A R Salomon; D W Voehringer; L A Herzenberg; C Khosla
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

4.  Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2.

Authors:  Jian-Guo Ren; Pankaj Seth; Peter Everett; Clary B Clish; Vikas P Sukhatme
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

Review 5.  Mitochondrial respiratory complex I: structure, function and implication in human diseases.

Authors:  Lokendra K Sharma; Jianxin Lu; Yidong Bai
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 6.  Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.

Authors:  Alexandra Wagner; Helena Kosnacova; Miroslav Chovanec; Dana Jurkovicova
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

7.  Targeting aspartate aminotransferase in breast cancer.

Authors:  Joshua Marshall Thornburg; Kristin K Nelson; Brian F Clem; Andrew N Lane; Sengodagounder Arumugam; Allan Simmons; John W Eaton; Sucheta Telang; Jason Chesney
Journal:  Breast Cancer Res       Date:  2008-10-15       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.